Couxin Ambroxol Hydrochloride 15 mg / 5 mL Oral Suspension

IMPORTANT NOTICE: This product is a pediatric-friendly oral mucolytic suspension formulated to thin and liquefy stubborn mucus and sticky phlegm in the respiratory tract. Always follow labeled directions or consult a pediatrician/physician for appropriate use. If symptoms persist for more than 5 to 7 days, or are accompanied by high fever or difficulty breathing, consult a licensed healthcare professional promptly.

Couxin Ambroxol Hydrochloride 15 mg / 5 mL Oral Suspension (Pediatric & Family Phlegm Relief, Targeted Mucolytic Care Sold per bottle of 60 mL) is an oral liquid formulation indicated for secretolytic therapy in acute and chronic bronchopulmonary conditions characterized by thick, viscous mucus and difficult expectoration.

• Packaging & Quantity: Sold per bottle of 60 mL (1 amber bottle with tamper-evident seal and measuring cup). Each 5 mL delivers 15 mg of active Ambroxol Hydrochloride.

• Targeted Secretolytic Action: Stimulates fluid secretion in the respiratory tract and breaks down mucopolysaccharide structures, transforming thick, stubborn phlegm into a looser, more fluid consistency for easier clearance.

• Targeted Respiratory Indications: Indicated for productive ("wet") coughs associated with acute and chronic bronchitis, tracheobronchitis, laryngitis, bronchiectasis, and other respiratory conditions with impaired mucus transport.

• Gentle Pediatric Strength: Formulated at 15 mg / 5 mL to facilitate accurate, lower-dose titration for infants, toddlers, and young children.

Directions for Use: Shake well before each use. Take orally using the included calibrated measuring cup or dropper, preferably after meals:

• Children 6 to 12 years: 5 mL (15 mg) 2 to 3 times daily.

• Children 2 to 5 years: 2.5 mL (7.5 mg) 3 times daily.

• Children under 2 years: 2.5 mL (7.5 mg) twice daily, or strictly under the supervision of a pediatrician.

Tip: Ensure adequate daily fluid/water intake to support the natural mucus-thinning action.

Do not combine concurrently with central cough suppressants/antitussives, as suppressing the cough reflex may prevent loosened phlegm from clearing.

• Safety Precautions & Warnings: Contraindicated in patients with known hypersensitivity to ambroxol or bromhexine. Use with caution in patients with a history of peptic ulcer disease or severe renal/hepatic impairment. Discontinue use and seek medical advice if unusual skin rashes, swelling, or digestive upset occurs.

• Storage Guidance: Store at temperatures not exceeding 30°C in a dry place protected from excessive heat, moisture, and direct sunlight. Keep the bottle tightly capped after each use and securely out of reach of children.

FDA Registration No.: DRP-269